Lepu Bio Raises $131 Million in Series A Funding for Immunotherapies

Life Science

Zai Lab Announces $77.5 Million Collaboration for Incyte’s PD-1 mAb

Life Science

Asieris Enters $73 Million Agreement for Global Rights to Cervical Lesion Treatment

Life Science

Yuhan Out-Licenses NASH Treatment to Boehringer in $870 Million Deal

Life Science

Chi-Med’s Parent, C.K. Hutchison, Sells $288 Million of Chi-Med Stock

Life Science

Oncimmune and Biodesix Form Strategic Partnership to Unlock Full Potential of EarlyCDT® Lung in US

Life Science

Chi-Med Announces Secondary Offering of American Depositary Shares

Life Science

Pfizer’s Avastin biosimilar wins FDA approval

Life Science

CMS In-Licenses Dry Eye, Psoriasis Treatments from India’s Sun Pharma

Life Science

PeptiDream Announces New Peptide Drug Conjugate (“PDC”) Collaboration Agreement with Novartis

Life Science

NMPA Accepts New Drug Application for IBI301, a Biosimilar Product Candidate of Rituximab (MabThera/Rituxan)

Life Science

IDT signs strategic partnership with Chinese medical sequencing firm ChosenMed

Life Science

Johnson & Johnson Opens JLABS @ Shanghai, a Life Science Incubator with 31 Resident Startups

Life Science

Yisheng Cleared to Start China Trials of PIKA-based Cancer Immunotherapy

Life Science

FDA approves expanded label for Regeneron/Sanofi’s Dupixent

Life Science